Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.2250 (4.98%) ($10.2250 - $10.2250) on Mon. Feb. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.94% (three month average) | RSI | 63 | Latest Price | $10.2250(4.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -3.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(37%) IWC(36%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -3.47% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) TBT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.47% (StdDev 6.94%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $10.06(1.64%) | 10 Day Moving Average | $9.77(4.66%) | 20 Day Moving Average | $9.26(10.42%) | To recent high | -14.1% | To recent low | 103.1% | Market Cap | $1.804b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |